Table 2.
Compounds | Bioactive constituent | In vivo/in vitro | Pharmacological functions | References |
---|---|---|---|---|
Carotenoid | Crocin | Mice | Neuroprotective | [22] |
Crocin and crocetin | Rat | Neuroprotective | [58] | |
Crocetin | Human | Antifatigue | [59] | |
Crocin | — | Anti-Alzheimer | [60] | |
Crocin | Human | Antischizophrenia | [61] | |
Monoterpene aldehydes | — | Human | Antidepressant | [23] |
Safranal | Mice | Anticonvulsant | [24] | |
Picrocrocin | — | Antiproliferative | [62] | |
Picrocrocin | — | Anticancer | [63] | |
Monoterpenoids | Crocusatin D | — | Withdrawal syndrome, depression, spatial memory | [64] |
Crocusatin F | ||||
Crocusatin G | ||||
Crocusatin H | ||||
Crocusatin E | ||||
Crocusatin I | ||||
Isophorones | Isomer of isophorone | Mice | Parkinson disease | [64] |
Isophorone | Hyperglycaemia–glucose uptake/metabolism | |||
General saffron extract | Crocin, crocetin, safranal, and picrocrocin | Mice | Anticancer effects, atherosclerosis, myocardial ischaemia, cardioprotection, anxiety, and insomnia | [64] |